Sickle cell gene therapies offer new hope, but access remains a major challenge
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
CNBC reports: FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
This business story centres on the United States.
Why it matters
Business and economic news can ripple through prices, jobs, investments and household budgets.
Key details
- Location
- United States · Americas
- Reported by
- CNBC
- First reported
- Section
- Business
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at CNBCSpotted an error? Request a correction · How this summary was produced
Related Stories
NCAA sues Ohio gov. over order allowing schools to ignore new eligibility rule
The NCAA has filed a federal lawsuit against Ohio Gov. Mike DeWine three days after he signed an executive order giving the state's colleges and…
NBA tells sportsbooks to prohibit certain bets, restrict parlays
The NBA is prohibiting certain bets this season, including a player prop parlay used in recent scandals, according to a league memo to sportsbook…
Jets rookie WR Cooper to play vs. Patriots; RB Hall, WR Mitchell out
Jets rookie WR Omar Cooper Jr. (ankle) will play against the Patriots, but RB Breece Hall and wideout Adonai Mitchell have been ruled out for…
Bold predictions: Players our experts feel differently about than seemingly everyone else
The fantasy basketball crew identifies one player they feel differently about than seemingly everyone else.
Analysis: Everyone expects the Fed to hold rates in October. Kevin Warsh could surprise us all
Investors expect the Fed to pause rate hikes in October, but Kevin Warsh's rejection of traditional communications practices and continued concern…
Target pensions or welfare, not banks, IMF tells John Healey
Helge Berger, deputy director of the IMF’s European department, was asked about bank taxes after the Guardian revealed Healey plans to tap the…
Kimberly-Clark is having its best week in four years. Here's what is propelling shares higher
After a bruising September for the stock, the good news is starting to pile up.
UK risks losing key role in European space industry over satellite contract, says Airbus boss
Guillaume Faury writes to Andy Burnham warning him against choosing US firm Lockheed Martin to build Skynet satellites The boss of Airbus has told…